Viewing nowPregabalin Capsule 150 mg (Pregabalin)
Pregabalin 150mg
Hard capsule · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

MFDS item code 201603689 · Approved 2016.06.21 · Insurance code 658203240
Treatment of peripheral and central neuropathic pain, adjunctive treatment for partial seizures in epilepsy, alleviation of fibromyalgia
This medication is used to treat peripheral and central neuropathic pain in adults. Additionally, it can be used as an adjunct for patients with epilepsy who experience partial seizures or have generalized symptoms. It is also effectively used for patients with fibromyalgia. In summary, this drug helps relieve neuropathic pain, manage epilepsy, and improve symptoms of fibromyalgia.
This medication should be administered orally, divided into two doses daily, regardless of meals. 1. Neuropathic pain 1) Peripheral neuropathic pain The starting dose is 150 mg per day, and can be increased to 300 mg per day within 3 to 7 days. If necessary, the dose can be increased to a maximum of 600 mg per day at 7-day intervals. 2) Central neuropathic pain The starting dose is 150 mg per day. After one week, it can be increased to 300 mg per day.
Administration in children under 12 years old and adolescents aged 12 to 17 is not recommended due to insufficient safety and efficacy data.
Careful monitoring for suicidal thoughts or behaviors, depression onset or worsening, and abnormal changes in mood and behavior is required during treatment with this medication. Patients with hypersensitivity to this medication should not take it. Diabetic patients may experience weight gain while taking this medication, which may require adjustment of blood sugar control medications. If allergic reactions such as angioedema occur, discontinue use immediately. Elderly patients should be particularly cautious as dizziness or drowsiness may occur after taking this medication, especially during the initial phase. Vision blurriness or changes in vision may occur; these symptoms can improve after stopping the medication. Sudden discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, nausea, and anxiety, and should therefore be tapered gradually under a physician's guidance. There is a potential risk of drug abuse or dependence, so patients with a history of drug abuse should be particularly careful and report any unusual signs immediately. Patients with impaired renal function may require dose adjustments. Patients with heart disease should exercise caution while taking this medication, especially those with congestive heart failure. The risk of respiratory depression may increase when used in conjunction with other central nervous system depressants, so caution is advised. This medication should not be used during early pregnancy due to the risk of congenital malformations, and sexually active women should utilize effective contraceptive methods. Breastfeeding women should consider discontinuing nursing or the medication as this drug can be transmitted through breast milk. Dizziness or drowsiness may occur, hence caution is advised when driving or operating dangerous machinery. Severe skin reactions may occur; if symptoms such as skin rashes arise, discontinue use immediately and consult a doctor. In the event of an overdose, symptoms such as confusion, drowsiness, depression, and agitation may occur, and treatment such as hemodialysis may be necessary. Special caution is necessary for children, the elderly, and patients with impaired renal function while taking this medication. This drug has minimal pharmacokinetic interactions with other drugs, but caution is advised as side effects may worsen when taken with other central nervous system depressants. Adhering to these precautions will help ensure safe therapeutic outcomes.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, cough with fever accompanying respiratory abnormalities, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headaches, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly closed container. It is recommended to maintain the storage temperature between 15 to 30 degrees Celsius.
A white hard capsule containing white powder
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Hard capsule · Prescription medication
Vivozon Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.